Bridging the Gap Between Theory and Practice in RA -- Understanding the Relationship Between Drug Mechanism of Action and Treatment Outcomes CME

Author Information and Disclosures

Release Date: May 27, 2008; Valid for credit through May 27, 2009

Credits Available
Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
BMS
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Review the theoretical basis of rheumatoid arthritis treatment with biologic therapy
  2. Understand that different therapeutic responses, including treatment failure, can be associated with the mechanism of action (MOA) of the therapeutic agent
  3. Recognize the impact of treatment failure on long-term patient outcomes
  4. Summarize the evidence supporting switching of therapeutic agents that have different MOAs to maximize treatment outcomes
Authors and Disclosures

Yusuf Yazici, MD
Disclosure: Yusuf Yazici, MD, has disclosed that he has received grants for educational activities from, and has served as an advisor or consultant to, Pfizer, Roche, Bristol-Myers Squibb, Celgene, and Centocor.


Helen Fosam, PhD
Disclosure: Helen Fosam, PhD, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.